Cellectis SA (CLLS)
1.76
-0.04
(-2.22%)
USD |
NASDAQ |
Nov 04, 16:00
1.77
+0.01
(+0.57%)
After-Hours: 20:00
Cellectis Price to Book Value: 1.192 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 1.212 |
| October 31, 2024 | 1.199 |
| October 30, 2024 | 1.226 |
| October 29, 2024 | 1.233 |
| October 28, 2024 | 1.300 |
| October 25, 2024 | 1.253 |
| October 24, 2024 | 1.280 |
| October 23, 2024 | 1.327 |
| October 22, 2024 | 1.212 |
| October 21, 2024 | 1.236 |
| October 18, 2024 | 1.280 |
| October 17, 2024 | 1.286 |
| October 16, 2024 | 1.280 |
| October 15, 2024 | 1.273 |
| October 14, 2024 | 1.313 |
| October 11, 2024 | 1.354 |
| October 10, 2024 | 1.347 |
| October 09, 2024 | 1.313 |
| October 08, 2024 | 1.320 |
| October 07, 2024 | 1.327 |
| October 04, 2024 | 1.276 |
| October 03, 2024 | 1.334 |
| October 02, 2024 | 1.320 |
| October 01, 2024 | 1.360 |
| September 30, 2024 | 1.428 |
| Date | Value |
|---|---|
| September 27, 2024 | 1.471 |
| September 26, 2024 | 1.475 |
| September 25, 2024 | 1.455 |
| September 24, 2024 | 1.488 |
| September 23, 2024 | 1.482 |
| September 20, 2024 | 1.520 |
| September 19, 2024 | 1.563 |
| September 18, 2024 | 1.536 |
| September 17, 2024 | 1.576 |
| September 16, 2024 | 1.549 |
| September 13, 2024 | 1.515 |
| September 12, 2024 | 1.616 |
| September 11, 2024 | 1.554 |
| September 10, 2024 | 1.495 |
| September 09, 2024 | 1.519 |
| September 06, 2024 | 1.509 |
| September 05, 2024 | 1.529 |
| September 04, 2024 | 1.549 |
| September 03, 2024 | 1.522 |
| August 30, 2024 | 1.616 |
| August 29, 2024 | 1.616 |
| August 28, 2024 | 1.596 |
| August 27, 2024 | 1.603 |
| August 26, 2024 | 1.616 |
| August 23, 2024 | 1.596 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5691
Minimum
Jun 16 2022
5.012
Maximum
Jan 19 2021
1.860
Average
1.736
Median
Price to Book Value Benchmarks
| Genfit SA | 2.754 |
| DBV Technologies SA | 0.9524 |
| Edap TMS SA | 1.976 |
| Adaptimmune Therapeutics PLC | 2.190 |
| Akari Therapeutics PLC | -- |
Price to Book Value Related Metrics
| PS Ratio | 10.66 |
| Price to Free Cash Flow | 2.710 |
| Price | 1.76 |
| Earnings Yield | -81.36% |
| Market Cap | 177.17M |